About Sterigenics
Sterigenics is a publicly listed company based in Oak Brook (United States) founded in 1978, and was acquired by GTCR in February 2011. Provider of comprehensive sterilization solutions and expert consulting services. The company has 3,000 employees. Sterigenics has completed 6 acquisitions, including Bioscience Laboratories, FTS International and Gibraltar Laboratories. Its chief executive, as recorded, is Michael Petras. Its website sterigenics.com draws about 16 thousand monthly visits. Sterigenics offers products and services including Ethylene Oxide Sterilization, Gamma Sterilization, and Electron Beam Sterilization. Its focus areas include Biopharma Outsourcing, Sterilization, Services for Healthcare Providers and Consultancy Services. Its legal entity is Sterigenics U.S., LLC. Its competitors include Heartland Dental, MB2 Dental Solutions and Keplr Vision; 2 of its 3 listed competitors have raised funding.
Company details
Sterigenics International, a portfolio company of Warburg Pincus and GTCR company provides contract sterilization and ionization services, microbiological and analytical testing and consultancy services. It offers services for the medical device, pharmaceutical, food safety, and high-performance materials industries. It also assists customers in developing and maintaining sterilization solutions in medical devices, tissueimplantable products and pharmaceuticals and biologics fields. It claims to be the worlds largest provider of Cobalt-60 that is used in the gamma sterilization process as well as medical isotopes for the diagnosis and treatment of various diseases and cancers. On April 4, 2016 it has acquired Nelson Laboratories, a provider of life-cycle microbiology testing services
- Headquarters Oak Brook, United States
- Employees 3,000
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website sterigenics.com
- Social LinkedIn X
- Acquired by GTCR (Feb 2011)
- Legal Name Sotera Health Company
- Annual Revenue$1.16 B (USD)5.74as on Dec 31, 2025
- Net Profit$77.94 M (USD)75.79as on Dec 31, 2025
- EBITDA$555.35 M (USD)10.17as on Dec 31, 2025
- InvestorsSummit Partners
& 1 more
- Employee Count3,000
- Investments & AcquisitionsBioscience Laboratories
& 5 more
- Acquired byGTCR
(Feb 2011)
Products & Services of Sterigenics
Sterigenics offers a comprehensive portfolio of products and services, including Ethylene Oxide Sterilization, Gamma Sterilization, and Electron Beam Sterilization.
Method for sterilizing medical devices and products using gas.
Radiation-based process for safe sterilization of pharmaceuticals.
High-energy beam technique for industrial product sterilization.
Funding Insights of Sterigenics
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Sterigenics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 1993 | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Sterigenics
Sterigenics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Summit Partners and GTCR Chicago Private Equity Firm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Summit Partners is recognized as a growth equity investment firm. | summitpartners.com | Boston, United States | ||
Private equity investments and firm management in Chicago. | gtcr.com |
Investor details for Sterigenics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sterigenics
34 people are tracked at Sterigenics (22 in leadership, 12 in team); the tracked headcount is 3,000.
| Name | Role | Group |
|---|---|---|
Michael Petras | CEO | Leadership |
Mike Rutz | President | Leadership |
John Kurth | Senior Director, PMO & Capex | Leadership |
Kevin Wagner | VP, Global Environmental Health & Safety | Leadership |
Shawn Ansari | VP, Global Engineering | Leadership |
Sergio Salas | VP, Americas, Radiation West | Leadership |
Kim Mirabelli | VP, Human Resources | Leadership |
Raj Mattu | Director, Global Strategy And Strategic Accounts | Leadership |
Crompton | Vice President Finance | Leadership |
Sally Roland | Global Medical Device Segment & Emeaa Strategy Director | Leadership |
Kevin O'Hara | Director, Radiation Physics | Leadership |
Greg Childress | Global Vice President Regional Sales | Leadership |
Amie Casson | Director Of Global Marketing | Leadership |
John Greene | Director Global Commercial Operations | Leadership |
Frank Sonnemans | Sr. Director Sales Emeaa | Leadership |
Mark Simpson | Director Of Electron Beam Engineering | Leadership |
Carrie Burkett | Director Of Strategic Accounts | Leadership |
Radu Grovu | Sr. Director, Engineering | Leadership |
Dan May | Director Environment, Health And Safety - Americas | Leadership |
Alain Smolders | IT Director Emeaa & Global Networks | Leadership |
14 more people are available in the full profile.
Complete people profiles for Sterigenics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Sterigenics
Sterigenics is a publicly listed company on the NASDAQ with ticker symbol SHC in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Nov 2020
- Listed onNASDAQ: SHC
- Listed entitySotera Health Company
- Exchange sectorHealth technology
- ISINUS83601L1026
- Share price$18.21 (+0.33% on the day) · 2026-10-13
- Market capitalisation$5.20B
- Price to earnings32.0
- EPS (diluted, trailing year)$0.57
- Volume (last session)1,647,777
Financials of Sterigenics
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $1.16B | $77.9M | $555.4M |
| 2024 | $1.10B | $44.3M | $504.1M |
| 2023 | $1.05B | $51.1M | $516.8M |
| 2022 | $1.00B | -$233.6M | $477.2M |
| 2021 | $931.5M | $115.4M | $453.6M |
Detailed financial statements for Sterigenics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sterigenics
Sterigenics has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Bioscience Laboratories, FTS International and Gibraltar Laboratories.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of regulatory affairs consulting services for pharmaceutical and medical device indutry | rcainc.com | Pleasant Prairie, United States | 2000 | Nov 2021 | •••• | |
Preclinical and clinical testing for topical antimicrobials is provided. | biosciencelabs.com | Bozeman, United States | 1991 | Mar 2021 | •••• | |
Sterilisation, bio-reduction, and materials modification services are provided. | iotron.com | Port Coquitlam, Canada | 1989 | Aug 2020 | •••• | |
Bio-analytical and sterilization services are provided to clients. | gibraltarlabsinc.com | Fairfield, United States | 1970 | Aug 2018 | •••• | |
Company offering microbiological testing services for the medical device, pharmaceutical and natural product industries | nelsonlabs.com | Salt Lake, United States | 1985 | Apr 2016 | •••• | |
Well stimulation services for the oil and gas industry | ftsi.com | Fort Worth, United States | 2002 | Dec 2013 | •••• |
Complete acquisition details for Sterigenics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sterigenics
10 dated milestones of Sterigenics across 43 years, from founding to its latest funding, stage changes and deals.
- Founded Sterigenics is founded.
- Funding First funding round.
- Exit Acquired by GTCR.
- Acquisition Acquires FTS International.
- Acquisition Acquires Nelson Laboratories.
- Acquisition Acquires Gibraltar Laboratories.
- Acquisition Acquires Iotron Industries.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Bioscience Laboratories.
- Acquisition Acquires Regulatory Compliance Associates.
Competitors of Sterigenics
Sterigenics has 3 listed competitors in our database, 2 of them funded. They include Heartland Dental, MB2 Dental Solutions and Keplr Vision.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| heartland.com | 1997 | Effingham, United States | $1.57M | 13,998 | Provider of healthcare consulting services | |
| mb2dental.com | 2007 | Carrollton, United States | 4,046 | Healthcare consulting services focused on dental solutions are provided. | ||
| keplrvision.com | 2019 | Bloomington, United States | $80M | Business support and supply chain management services are offered. |
Detailed competitors of Sterigenics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sterigenics
The website of Sterigenics (sterigenics.com) receives about 15.5K visits a month.
- Monthly visits15.5K
▼ 10.4% vs previous month
Websites whose visitors overlap most with Sterigenics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ebeamservices.com | ebeamservices.com | 100% | #3,614,560 | – | |
| steris.com | 100% | 361.8K | #148,669 | View details | |
| pure11.de | 99% | 4.5K | #4,136,905 | View details | |
pfmmedical.de | pfmmedical.de | 94% | #2,788,029 | – | |
| steris-ast.com | 91% | 32.6K | #990,717 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 28 similar websites and full traffic analytics for Sterigenics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 28 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Sterigenics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sterigenics
Complete news archive for Sterigenics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sterigenics
Sterigenics was founded in 1978 and raised its 1st funding round 15 years after it was founded.
Sterigenics is headquartered in Oak Brook, United States. It is registered at Oak Brook, Illinois, United States.
Michael Petras is the CEO of Sterigenics, as recorded in our data.
Sterigenics has 3,000 employees.
Annual revenue of Sterigenics is $1.16B as on Dec 31, 2025.
Sterigenics International, a portfolio company of Warburg Pincus and GTCR company provides contract sterilization and ionization services, microbiological and analytical testing and consultancy services. It offers services for the medical device, pharmaceutical, food safety, and high-performance materials industries. It also assists customers in developing and maintaining sterilization solutions in medical devices, tissueimplantable products and pharmaceuticals and biologics fields. It claims to be the worlds largest provider of Cobalt-60 that is used in the gamma sterilization process as well as medical isotopes for the diagnosis and treatment of various diseases and cancers. On April 4, 2016 it has acquired Nelson Laboratories, a provider of life-cycle microbiology testing services.
Sterigenics's top competitors include Heartland Dental, MB2 Dental Solutions and Keplr Vision.
Sterigenics offers Ethylene Oxide Sterilization, Gamma Sterilization, and Electron Beam Sterilization.
Yes, Sterigenics is publicly traded on NASDAQ under the ticker symbol SHC.
Sterigenics has made 6 acquisitions, including Bioscience Laboratories, FTS International, and Gibraltar Laboratories.
Sterigenics has 2 investors. Key investors include Summit Partners, and GTCR Chicago Private Equity Firm.
Sterigenics operates through Sterigenics U.S., Llc.